Literature DB >> 25729481

Role of surgical resection for hepatocellular carcinoma based on Japanese clinical guidelines for hepatocellular carcinoma.

Hisashi Nakayama1, Tadatoshi Takayama1.   

Abstract

In the Algorithm for Diagnosis and Treatment in the Japanese Evidence-Based Clinical Practice Guidelines for Hepatocellular Carcinoma, the treatment strategy is determined by three major factors: liver function and the number and size of tumors. The algorithm is quite simple, consisting of fewer components than the Barcelona-Clinic Liver Cancer staging system. In this article, we describe the roles of the treatment algorithm in hepatectomy and perioperative management of hepatocellular carcinoma.

Entities:  

Keywords:  Guideline; Hepatocellular carcinoma; Liver resection; Treatment algorithm

Year:  2015        PMID: 25729481      PMCID: PMC4342608          DOI: 10.4254/wjh.v7.i2.261

Source DB:  PubMed          Journal:  World J Hepatol


  83 in total

1.  Proposal of objective morphological classification system for hepatocellular carcinoma using preoperative multiphase computed tomography.

Authors:  Hisashi Nakayama; Tadatoshi Takayama; Takao Okubo; Tokio Higaki; Yutaka Midorikawa; Masamichi Moriguchi; Akiyoshi Itoh
Journal:  J Gastroenterol       Date:  2013-11-16       Impact factor: 7.527

2.  The predictive value of postoperative clinical risk scores for outcome after hepatic resection: a validation analysis in 807 patients.

Authors:  Nuh N Rahbari; Christoph Reissfelder; Moritz Koch; Heike Elbers; Fabian Striebel; Markus W Büchler; Jürgen Weitz
Journal:  Ann Surg Oncol       Date:  2011-06-15       Impact factor: 5.344

3.  Improved results of liver resection for hepatocellular carcinoma on cirrhosis give the procedure added value.

Authors:  G L Grazi; G Ercolani; F Pierangeli; M Del Gaudio; M Cescon; A Cavallari; A Mazziotti
Journal:  Ann Surg       Date:  2001-07       Impact factor: 12.969

4.  Validation of a new prognostic staging system for hepatocellular carcinoma: the JIS score compared with the CLIP score.

Authors:  Masatoshi Kudo; Hobyung Chung; Seiji Haji; Yukio Osaki; Hiroko Oka; Toshihito Seki; Hiroshi Kasugai; Yo Sasaki; Takashi Matsunaga
Journal:  Hepatology       Date:  2004-12       Impact factor: 17.425

Review 5.  Hepatocellular carcinoma.

Authors:  Alejandro Forner; Josep M Llovet; Jordi Bruix
Journal:  Lancet       Date:  2012-02-20       Impact factor: 79.321

6.  Randomized clinical trial of the effects of abdominal drainage after elective hepatectomy using the crushing clamp method.

Authors:  H-C Sun; L-X Qin; L Lu; L Wang; Q-H Ye; N Ren; J Fan; Z-Y Tang
Journal:  Br J Surg       Date:  2006-04       Impact factor: 6.939

7.  Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma.

Authors:  Takeaki Ishizawa; Kiyoshi Hasegawa; Taku Aoki; Michiro Takahashi; Yosuke Inoue; Keiji Sano; Hiroshi Imamura; Yasuhiko Sugawara; Norihiro Kokudo; Masatoshi Makuuchi
Journal:  Gastroenterology       Date:  2008-03-08       Impact factor: 22.682

8.  Three hundred and one consecutive extended right hepatectomies: evaluation of outcome based on systematic liver volumetry.

Authors:  Yoji Kishi; Eddie K Abdalla; Yun Shin Chun; Daria Zorzi; David C Madoff; Michael J Wallace; Steven A Curley; Jean-Nicolas Vauthey
Journal:  Ann Surg       Date:  2009-10       Impact factor: 12.969

9.  Postoperative liver dysfunction and future remnant liver: where is the limit? Results of a prospective study.

Authors:  Alessandro Ferrero; Luca Viganò; Roberto Polastri; Andrea Muratore; Haris Eminefendic; Daniele Regge; Lorenzo Capussotti
Journal:  World J Surg       Date:  2007-08       Impact factor: 3.352

10.  Management of hepatocellular carcinoma: an update.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2011-03       Impact factor: 17.425

View more
  10 in total

Review 1.  Management before hepatectomy for hepatocellular carcinoma with cirrhosis.

Authors:  Hisashi Nakayama; Tadatoshi Takayama
Journal:  World J Hepatol       Date:  2015-09-18

2.  Short-term surgical outcomes of minimally invasive repeat hepatectomy for recurrent liver cancer.

Authors:  Takehiro Noda; Hidetoshi Eguchi; Hiroshi Wada; Yoshifumi Iwagami; Daisaku Yamada; Tadafumi Asaoka; Kunihito Gotoh; Koichi Kawamoto; Yutaka Takeda; Masahiro Tanemura; Koji Umeshita; Yuichiro Doki; Masaki Mori
Journal:  Surg Endosc       Date:  2017-06-21       Impact factor: 4.584

3.  Role of ablation: should it be used as primary therapy for early-stage hepatocellular carcinoma?

Authors:  Maurizio Pompili; Giampiero Francica
Journal:  Hepat Oncol       Date:  2015-11-06

4.  Validation of the liver mean dose in terms of the biological effective dose for the prevention of radiation-induced liver damage.

Authors:  Hiroshi Doi; Norihisa Masai; Kenji Uemoto; Osamu Suzuki; Hiroya Shiomi; Daisaku Tatsumi; Ryoong-Jin Oh
Journal:  Rep Pract Oncol Radiother       Date:  2017-05-05

5.  MicroRNA-129-5p promotes proliferation and metastasis of hepatocellular carcinoma by regulating the BMP2 gene.

Authors:  Zengyao Liu; Jiefei Sun; Xiaochun Wang; Zhenyuan Cao
Journal:  Exp Ther Med       Date:  2021-01-25       Impact factor: 2.447

6.  Proliferation and motility of hepatocellular, pancreatic and gastric cancer cells grown in a medium without glucose and arginine, but with galactose and ornithine.

Authors:  Minoru Tomizawa; Fuminobu Shinozaki; Yasufumi Motoyoshi; Takao Sugiyama; Shigenori Yamamoto; Naoki Ishige
Journal:  Oncol Lett       Date:  2017-01-04       Impact factor: 2.967

Review 7.  Update on perioperative management of patients undergoing surgery for liver cancer.

Authors:  Masaki Kaibori; Kosuke Matsui; Mitsuo Shimada; Shoji Kubo; Kiyoshi Hasegawa
Journal:  Ann Gastroenterol Surg       Date:  2021-12-15

8.  Prognostic value of liver stiffness measurement for the liver-related surgical outcomes of patients under hepatic resection: A meta-analysis.

Authors:  Zitong Huang; Jingjing Huang; Tianran Zhou; Hongying Cao; Bo Tan
Journal:  PLoS One       Date:  2018-01-11       Impact factor: 3.240

9.  Complete Remission after Sequential Therapy of Drug Eluting Beads Transarterial Chemoembolization and Liver Resection in Large Solitary Nodule Hepatocellular Carcinoma.

Authors:  Juferdy Kurniawan; Andri Sanityoso Sulaiman; Sahat Basana Romanti Ezer Matondang; Toar Jean Maurice Lalisang; Ening Krisnuhoni; Steven Zulkifly
Journal:  Case Reports Hepatol       Date:  2017-09-27

10.  Recurrence Risk of Liver Cancer Post-hepatectomy Using Machine Learning and Study of Correlation With Immune Infiltration.

Authors:  Xiaowen Qian; Huilin Zheng; Ke Xue; Zheng Chen; Zhenhua Hu; Lei Zhang; Jian Wan
Journal:  Front Genet       Date:  2021-12-08       Impact factor: 4.599

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.